St. Croix Hospice Secures Top Quality Connections Ranking for 6th Year
St. Croix Hospice maintains its industry-leading status by completing all four rings of the National Alliance for Care at Home's Quality Connections…
St. Croix Hospice maintains its industry-leading status by completing all four rings of the National Alliance for Care at Home's Quality Connections…
CSL Seqirus completes its 2026/27 influenza vaccine production cycle, bolstering U.S. supply chains as the company fulfills the bulk of its seasonal…
New data confirms DispatchHealth's home-based care model reduces inpatient costs and total care expenditures for Regence BlueShield members, signaling a shift toward…
SeaStar Medical's CMO highlights QUELIMMUNE therapy for pediatric acute kidney injury in an upcoming oral presentation at a medical symposium.
Beta Bionics faces a securities fraud class action after a 37% stock decline triggered by allegations of misleading disclosures concerning its iLet…
NeuroSense Therapeutics management prepares for investor engagement at the 5th Annual ROTH Healthcare Opportunities Conference scheduled for September 29, 2026.
Hard Rock International initiates its 27th annual PINKTOBER campaign, utilizing global hospitality assets and exclusive merchandise to support breast cancer research and…
Dose expands its wellness portfolio with a new clinically studied liquid supplement aimed at improving blood flow and maintaining healthy blood pressure…
SkinCure Oncology reports 150,000 patients treated with its GentleCure IGSRT technology, underscoring the firm's growing commercial presence in the nonmelanoma skin cancer…
Clorox is merging CloroxPro with Purell-maker GOJO to strengthen its B2B footprint and offer healthcare customers a comprehensive suite of professional hygiene…
ECGI Holdings enters the $5.3 trillion U.S. healthcare industry through a proposed acquisition of Avanta Group, leveraging specialized expertise in AI-enabled health…
Lakewood-Amedex shares gain momentum as the company reports successful clinical data for its Nu-3 Bisphosphocin candidate, targeting the treatment of diabetic foot…